Galenfeha R&D Spending Growth & History (NGHI)
Galenfeha's r&d spending was $3,788 for fiscal 2017.
View full Galenfeha company overviewGalenfeha annual r&d spending history
| Fiscal year | Period ended | R&D spending | Change | Growth |
|---|---|---|---|---|
| 2017 | 2017-12-31 | $3,788 | $3,788 | — |
| 2016 | 2016-12-31 | $0 | −$174,465 | — |
| 2015 | 2015-12-31 | $174,465 | $115,617 | +196.47% |
| 2014 | 2014-12-31 | $58,848 | $46,586 | +379.92% |
| 2013 | 2013-12-31 | $12,262 | — | — |
Galenfeha quarterly r&d spending
| Fiscal quarter | Period ended | R&D spending | Change | YoY change |
|---|---|---|---|---|
| Q3 2017 | 2017-09-30 | $3,788 | $3,788 | — |
| Q3 2016 | 2016-09-30 | $0 | −$107,955 | — |
| Q2 2016 | 2016-06-30 | $39 | −$97,436 | −99.96% |
| Q1 2016 | 2016-03-31 | $21,174 | $19,573 | +1222.55% |
| Q3 2015 | 2015-09-30 | $107,955 | $107,955 | — |
| Q2 2015 | 2015-06-30 | $97,475 | $81,125 | +496.18% |
| Q1 2015 | 2015-03-31 | $1,601 | −$20,703 | −92.82% |
| Q4 2014 | 2014-12-31 | $20,194 | $20,194 | — |
| Q3 2014 | 2014-09-30 | $0 | −$12,262 | — |
| Q2 2014 | 2014-06-30 | $16,350 | $16,350 | — |
| Q1 2014 | 2014-03-31 | $22,304 | $22,304 | — |
| Q4 2013 | 2013-12-31 | $0 | — | — |
| Q3 2013 | 2013-09-30 | $12,262 | — | — |
| Q2 2013 | 2013-06-30 | $0 | — | — |
| Q1 2013 | 2013-03-31 | $0 | — | — |
Galenfeha r&d spending trends
Between the periods ended 2013-12-31 and 2017-12-31, Galenfeha's r&d spending decreased from $12,262 to $3,788, a change of −$8,474. The latest reported quarter, Q3 2017, shows $3,788.
What research and development spending means
Research and development (R&D) spending covers the costs of creating and improving products, services, software, technologies, and processes. Higher R&D spending may support future innovation, but the amount alone does not show whether those investments will generate returns.
SEC-reported R&D expense
TickerStat standardizes research and development expense reported in company SEC filings, including the software-specific US-GAAP R&D concept when it is the filer’s primary R&D expense line. It is historical company-reported spending, not an estimate or forecast. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Galenfeha source filings ↗